BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28121683)

  • 1. Interstage Assessment of Remnant Liver Function in ALPPS Using Hepatobiliary Scintigraphy: Prediction of Posthepatectomy Liver Failure and Introduction of the HIBA Index.
    Serenari M; Collaud C; Alvarez FA; de Santibañes M; Giunta D; Pekolj J; Ardiles V; de Santibañes E
    Ann Surg; 2018 Jun; 267(6):1141-1147. PubMed ID: 28121683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?
    Chapelle T; Op De Beeck B; Huyghe I; Francque S; Driessen A; Roeyen G; Ysebaert D; De Greef K
    HPB (Oxford); 2016 Jun; 18(6):494-503. PubMed ID: 27317953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of hepatobiliary scintigraphy in assessing ALPPS most suited timing.
    Truant S; Baillet C; Deshorgue AC; El Amrani M; Huglo D; Pruvot FR
    Updates Surg; 2017 Sep; 69(3):411-419. PubMed ID: 28795384
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Olthof PB; Coelen RJS; Bennink RJ; Heger M; Lam MF; Besselink MG; Busch OR; van Lienden KP; van Gulik TM
    HPB (Oxford); 2017 Oct; 19(10):850-858. PubMed ID: 28687148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single-center pilot study.
    Serenari M; Bonatti C; Zanoni L; Peta G; Tabacchi E; Cucchetti A; Ravaioli M; Pettinato C; Bagni A; Siniscalchi A; D'Errico A; Golfieri R; Fanti S; Cescon M
    Updates Surg; 2021 Feb; 73(1):197-208. PubMed ID: 33136280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver kinetic growth rate predicts postoperative liver failure after ALPPS.
    Kambakamba P; Stocker D; Reiner CS; Nguyen-Kim TD; Linecker M; Eshmuminov D; Petrowsky H; Clavien PA; Lesurtel M
    HPB (Oxford); 2016 Oct; 18(10):800-805. PubMed ID: 27524732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary scintigraphy and kinetic growth rate predict liver failure after ALPPS: a multi-institutional study.
    Tomassini F; D'Asseler Y; Linecker M; Giglio MC; Castro-Benitez C; Truant S; Axelsson R; Olthof PB; Montalti R; Serenari M; Chapelle T; Lucidi V; Sparrelid E; Adam R; Van Gulik T; Pruvot FR; Clavien PA; Bruzzese D; Geboes K; Troisi RI
    HPB (Oxford); 2020 Oct; 22(10):1420-1428. PubMed ID: 32057681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of proportionate kinetic growth rate fraction in future remnant liver function over volume determined by
    Lam HD; van der Pas SL; Baranski A; van Hoek B; Burgmans MC; Bennink RJ; de Geus-Oei LF
    Surgery; 2019 Jun; 165(6):1244-1245. PubMed ID: 30467041
    [No Abstract]   [Full Text] [Related]  

  • 9. Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection.
    Cieslak KP; Bennink RJ; de Graaf W; van Lienden KP; Besselink MG; Busch OR; Gouma DJ; van Gulik TM
    HPB (Oxford); 2016 Sep; 18(9):773-80. PubMed ID: 27593595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of the future remnant liver function is a better tool to predict post-hepatectomy liver failure than platelet-based liver scores.
    Chapelle T; Op de Beeck B; Driessen A; Roeyen G; Bracke B; Hartman V; Huyghe I; Morrison S; Ysebaert D; Francque S
    Eur J Surg Oncol; 2017 Dec; 43(12):2277-2284. PubMed ID: 28988766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function.
    Olthof PB; Tomassini F; Huespe PE; Truant S; Pruvot FR; Troisi RI; Castro C; Schadde E; Axelsson R; Sparrelid E; Bennink RJ; Adam R; van Gulik TM; de Santibanes E
    Surgery; 2017 Oct; 162(4):775-783. PubMed ID: 28732555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally Invasive Stage 1 to Protect Against the Risk of Liver Failure: Results from the Hepatocellular Carcinoma Series of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Italian Registry.
    Serenari M; Ratti F; Zanello M; Guglielmo N; Mocchegiani F; Di Benedetto F; Nardo B; Mazzaferro V; Cillo U; Massani M; Colledan M; Dalla Valle R; Cescon M; Vivarelli M; Colasanti M; Ettorre GM; Aldrighetti L; Jovine E
    J Laparoendosc Adv Surg Tech A; 2020 Oct; 30(10):1082-1089. PubMed ID: 32907480
    [No Abstract]   [Full Text] [Related]  

  • 13. Impaired Value of 99m Tc-GSA Scintigraphy as an Independent Risk Factor for Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
    Nakamura I; Iimuro Y; Hai S; Kondo Y; Hatano E; Fujimoto J
    Eur Surg Res; 2018; 59(1-2):12-22. PubMed ID: 29332090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring future liver remnant function prior to hepatectomy may guide the indication for portal vein occlusion and avoid posthepatectomy liver failure: a prospective interventional study.
    Chapelle T; Op de Beeck B; Roeyen G; Bracke B; Hartman V; De Greef K; Huyghe I; Van der Zijden T; Morrison S; Francque S; Ysebaert D
    HPB (Oxford); 2017 Feb; 19(2):108-117. PubMed ID: 27956027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients.
    Lin XJ; Yang J; Chen XB; Zhang M; Xu MQ
    J Surg Res; 2014 May; 188(2):489-95. PubMed ID: 24569034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization.
    Cieslak KP; Huisman F; Bais T; Bennink RJ; van Lienden KP; Verheij J; Besselink MG; Busch ORC; van Gulik TM
    Surgery; 2017 Jul; 162(1):37-47. PubMed ID: 28365007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tc-99m mebrofenin hepatobiliary scintigraphy to assess future liver remnant function before major liver surgery.
    Smet H; Martin D; Uldry E; Duran R; Girardet R; Schaefer N; Prior JO; Denys A; Halkic N; Demartines N; Melloul E
    J Surg Oncol; 2023 Dec; 128(8):1312-1319. PubMed ID: 37638473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of primary indication and liver function between stages: results of a multicenter Italian audit of ALPPS 2012-2014.
    Serenari M; Zanello M; Schadde E; Toschi E; Ratti F; Gringeri E; Masetti M; Cillo U; Aldrighetti L; Jovine E;
    HPB (Oxford); 2016 May; 18(5):419-27. PubMed ID: 27154805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary scintigraphy to predict postoperative liver failure after major liver resection; a multicenter cohort study in 547 patients.
    Olthof PB; Arntz P; Truant S; El Amrani M; Dasari BVM; Tomassini F; Troisi RI; Bennink RJ; Grunhagen D; Chapelle T; Op de Beeck B; Zanoni L; Serenari M; Erdmann JI
    HPB (Oxford); 2023 Apr; 25(4):417-424. PubMed ID: 36759303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS.
    Chan ACY; Chok K; Dai JWC; Lo CM
    Surgery; 2017 Feb; 161(2):357-364. PubMed ID: 27596751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.